GENinCode (LON:GENI) Shares Down 12.3% – Here’s What Happened

GENinCode Plc (LON:GENIGet Free Report)’s stock price traded down 12.3% during trading on Tuesday . The stock traded as low as GBX 2.50 ($0.03) and last traded at GBX 2.50 ($0.03). 2,380,361 shares were traded during mid-day trading, an increase of 222% from the average session volume of 740,144 shares. The stock had previously closed at GBX 2.85 ($0.04).

GENinCode Stock Performance

The firm has a market capitalization of £4.44 million, a price-to-earnings ratio of -0.73 and a beta of 0.66. The company has a 50-day moving average price of GBX 3.64 and a 200-day moving average price of GBX 4.15. The company has a quick ratio of 15.89, a current ratio of 2.60 and a debt-to-equity ratio of 9.28.

About GENinCode

(Get Free Report)

GENinCode Plc is a UK based company specialising in genetic risk assessment of cardiovascular disease. Cardiovascular disease is the leading cause of death and disability worldwide.

GENinCode operates business units in the UK, in the United States through GENinCode U.S. Inc and in Europe through GENinCode S.L.U.

GENinCode predictive technology provides patients and physicians with globally leading preventative care and treatment strategies.

Recommended Stories

Receive News & Ratings for GENinCode Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for GENinCode and related companies with MarketBeat.com's FREE daily email newsletter.